title: Sex differences in kidney gene expression during the life cycle of F344 rats.
abstract: BACKGROUND
  The kidney functions in key physiological processes to filter blood and regulate blood pressure via key molecular transporters and ion channels. Sex-specific differences have been observed in renal disease incidence and progression, as well as acute kidney injury in response to certain drugs. Although advances have been made in characterizing the molecular components involved in various kidney functions, the molecular mechanisms responsible for sex differences are not well understood. We hypothesized that the basal expression levels of genes involved in various kidney functions throughout the life cycle will influence sex-specific susceptibilities to adverse renal events.
  
  
  METHODS
  Whole genome microarray gene expression analysis was performed on kidney samples collected from untreated male and female Fischer 344 (F344) rats at eight age groups between 2 and 104 weeks of age.
  
  
  RESULTS
  A combined filtering approach using statistical (ANOVA or pairwise t test, FDR 0.05) and fold-change criteria (>1.5 relative fold change) was used to identify 7,447 unique differentially expressed genes (DEGs). Principal component analysis (PCA) of the 7,447 DEGs revealed sex-related differences in mRNA expression at early (2 weeks), middle (8, 15, and 21 weeks), and late (104 weeks) ages in the rat life cycle. Functional analysis (Ingenuity Pathway Analysis) of these sex-different genes indicated over-representation of specific pathways and networks including renal tubule injury, drug metabolism, and immune cell and inflammatory responses. The mRNAs that code for the qualified urinary protein kidney biomarkers KIM-1, Clu, Tff3, and Lcn2 were also observed to show sex differences.
  
  
  CONCLUSIONS
  These data represent one of the most comprehensive in-life time course studies to be published, assessing sex differences in global gene expression in the F344 rat kidney. PCA and Venn analyses reveal specific periods of sexually dimorphic gene expression which are associated with functional categories (xenobiotic metabolism and immune cell and inflammatory responses) of key relevance to acute kidney injury and chronic kidney disease, which may underlie sex-specific susceptibility. Analysis of the basal gene expression patterns of renal genes throughout the life cycle of the rat will improve the use of current and future renal biomarkers and inform our assessments of kidney injury and disease.
authors.affiliation: Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA. Joshua.Kwekel@fda.hhs.gov.
authors.forename: Joshua C
authors.initials: JC
authors.lastname: Kwekel
authors.forename: Varsha G
authors.initials: VG
authors.lastname: Desai
authors.forename: Carrie L
authors.initials: CL
authors.lastname: Moland
authors.forename: Vikrant
authors.initials: V
authors.lastname: Vijay
authors.forename: James C
authors.initials: JC
authors.lastname: Fuscoe
references.citation: J Appl Toxicol. 2010 Mar;30(2):172-82
references.pmid: 19839026
references.citation: Nutrition. 2005 Jun;21(6):775-7
references.pmid: 15925305
references.citation: Expert Opin Drug Metab Toxicol. 2012 Sep;8(9):1173-88
references.pmid: 22769852
references.citation: Nat Rev Drug Discov. 2004 Aug;3(8):711-5
references.pmid: 15286737
references.citation: J Toxicol Sci. 2012;37(4):863-9
references.pmid: 22863866
references.citation: BMC Genomics. 2010 Nov 30;11:675
references.pmid: 21118493
references.citation: Nat Biotechnol. 2010 May;28(5):486-94
references.pmid: 20458319
references.citation: Kidney Int. 2001 Jun;59(6):2233-42
references.pmid: 11380826
references.citation: Pflugers Arch. 2007 Dec;455(3):397-429
references.pmid: 17638010
references.citation: Arch Toxicol. 2004 Jul;78(7):369-77
references.pmid: 15114436
references.citation: Int J Mol Sci. 2012;13(8):10523-36
references.pmid: 22949877
references.citation: Curr Opin Nephrol Hypertens. 2001 Mar;10(2):219-25
references.pmid: 11224697
references.citation: Natl Toxicol Program Tech Rep Ser. 1990 Jan;347:1-165
references.pmid: 12704437
references.citation: Nat Biotechnol. 2010 May;28(5):463-9
references.pmid: 20458316
references.citation: Gend Med. 2008;5 Suppl A:S3-S10
references.pmid: 18395681
references.citation: Regul Toxicol Pharmacol. 2012 Feb;62(1):29-40
references.pmid: 22154824
references.citation: Adv Ren Replace Ther. 2003 Jan;10(1):3-14
references.pmid: 12616458
references.citation: Am J Pathol. 2004 Feb;164(2):679-88
references.pmid: 14742271
references.citation: Clin Invest Med. 2003 Feb;26(1):38-44
references.pmid: 12659469
references.citation: Hypertension. 2012 Oct;60(4):991-7
references.pmid: 22949537
references.citation: Pharmacol Rev. 2010 Mar;62(1):1-96
references.pmid: 20103563
references.citation: Kidney Int. 2002 Jul;62(1):237-44
references.pmid: 12081583
references.citation: Lipids Health Dis. 2012 Mar 16;11:41
references.pmid: 22423898
references.citation: Mol Pharmacol. 2009 Aug;76(2):215-28
references.pmid: 19483103
references.citation: Methods Mol Biol. 2009;563:379-98
references.pmid: 19597796
references.citation: Kidney Blood Press Res. 2007;30(2):67-80
references.pmid: 17268203
references.citation: Ann Hematol. 2012 Aug;91(8):1257-64
references.pmid: 22456893
references.citation: Chem Res Toxicol. 2002 Jan;15(1):15-20
references.pmid: 11800592
references.citation: Am J Nephrol. 2012;36(3):245-51
references.pmid: 22964976
references.citation: Pharmacogenomics. 2011 Feb;12(2):235-49
references.pmid: 21332316
references.citation: Curr Clin Pharmacol. 2009 Sep;4(3):229-32
references.pmid: 19500072